About Us
Company Overview
Taurus Vaccines LLC, founded in 2024 and headquartered in Austin, Texas, is a biotechnology company dedicated to the development of innovative vaccines for livestock, including cattle, horses, goats, and sheep. Leveraging a proprietary technological platform, Taurus Vaccines designs and develops next-generation vaccine candidates aimed at combating both common and emerging infectious diseases in production animals.
Our platform technology—based on a safe and adjuvanting double-attenuated influenza virus vector—enables the induction of robust cellular and humoral immune responses, including strong cytotoxic T lymphocyte (CTL) activation and targeted antibody production. This dual-response capability is particularly valuable for addressing rapidly mutating pathogens and diseases with mucosal or systemic transmission routes.
Taurus Vaccines focuses on the early-stage development of fully characterized vaccine candidates, either for internal pipeline targets or as custom solutions for partners. While the company does not engage in the commercial sale of vaccines, it specializes in the research, design, and pre-licensing development of vaccine products, offering them to commercial vaccine manufacturers and distributors through licensing agreements.
In addition to vaccine development, Taurus Vaccines provides support for field trials and regulatory registration, helping ensure a smooth transition from laboratory innovation to market-ready solutions.
Our mission is to bridge the gap between cutting-edge immunological science and the practical needs of livestock health, accelerating the availability of effective, science-driven vaccines for the global animal health industry.
Business Info
Location
5900 Balcones Drive Suite 100,
Austin, TX 78731
United States of America